EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Implementing a Bayesian approach using Stan with Torsten: Population pharmacokinetics analysis of somatrogon

Yuchen Wang iD, Xinyi Pei iD, Tao Niu iD, Joan Korth-Bradley iD, Luke Fostvedt iD

CPT: Pharmacometrics & Systems Pharmacology · 2025

DOI: 10.1002/psp4.13279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, 2025. Verfasst von Yuchen Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pfizer Inc., South San Francisco, California, USA. Hauptthemen laut MEDLINE: Models, Biological, Software, Human Growth Hormone. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fully Bayesian approaches are not commonly implemented for population pharmacokinetic (PK) modeling. In this paper, we evaluate the use of Stan with R and Torsten for population PK modeling of somatrogon, a recombinant long‐acting growth hormone approved for the treatment of growth hormone deficiency. As a software for Bayesian inference, Stan provides an easy way to conduct MCMC sampling for a wide range of models with efficient sampling algorithms, and there are several diagnostic tools to evaluate the MCMC convergence and other potential issues. Three different sets of priors were evaluated for estimation and prediction: a weakly informative uniform set, a moderately informative set, and a very informative set of priors. All three prior sets showed good performance and all chains mixed well. There were some minor differences in the final parameter posterior distributions while implementing different prior sets, but the posterior predictions covered the observations nicely, not only for the individuals included in posterior sampling but also for new individuals. The impact of a centered versus non‐centered parameterization were evaluated, with the non‐centered approach improving the estimation time, but it was still computationally intensive. Computational resources had the biggest impact on sampling time. Stan took approximately 2.5 h total for the MCMC sampling on a high‐performance computing platform (6 cores) and may be reduced further with additional computational resources. The model and comparisons presented show that with adequate computational resources, the Bayesian approaches using Stan and Torsten are useful for population PK analysis, especially for the analysis of special populations, small sample datasets, and when complex model structures are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Models, BiologicalSoftwareHuman Growth HormoneBayes TheoremHumansAlgorithmsComputer Simulation

Substanzen

Human Growth Hormonesomatrogon

Autor:innen und Institutionen

  • Pfizer Inc., South San Francisco, California, USA.
  • Department of Statistics, Purdue University, West Lafayette, Indiana, USA.
  • Pfizer Inc., Collegeville, Pennsylvania, USA.
  • Pfizer Inc., Cambridge, Massachusetts, USA.

ORCID-Profile: Yuchen Wang, Xinyi Pei, Tao Niu, Joan Korth-Bradley, Luke Fostvedt

Zitieren

APA

Wang, Y., Pei, X., Niu, T., Korth-Bradley, J., & Fostvedt, L. (2025). Implementing a Bayesian approach using Stan with Torsten: Population pharmacokinetics analysis of somatrogon. CPT: Pharmacometrics & Systems Pharmacology. https://doi.org/10.1002/psp4.13279

Vancouver

Wang Y, Pei X, Niu T, Korth-Bradley J, Fostvedt L. Implementing a Bayesian approach using Stan with Torsten: Population pharmacokinetics analysis of somatrogon. CPT: Pharmacometrics & Systems Pharmacology. 2025. doi:10.1002/psp4.13279

BibTeX
@article{Wang2025,
  author = {Wang, Yuchen and Pei, Xinyi and Niu, Tao and Korth-Bradley, Joan and Fostvedt, Luke},
  title = {Implementing a Bayesian approach using Stan with Torsten: Population pharmacokinetics analysis of somatrogon},
  journal = {CPT: Pharmacometrics & Systems Pharmacology},
  year = {2025},
  doi = {10.1002/psp4.13279}
}
Kostenlos starten →